BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 5861069)

  • 1. The synergistic anti-neoplastic activity of combinations of mitomycins with either 6-thioguanine or 5-fluorouracil.
    Sartorelli AC; Booth BA
    Cancer Res; 1965 Oct; 25(9):1393-400. PubMed ID: 5861069
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of the growth of sarcoma 180 ascites cells by combinations of inhibitors of nucleic acid biosynthesis and the cupric chelate of kethoxal bis-(thiosemicarbazone).
    Sartorelli AC; Booth BA
    Cancer Res; 1967 Sep; 27(9):1614-9. PubMed ID: 6051275
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitumor activity and mode of action of 2-thio-6-azauridine (NSC-146268) on L1210 leukemia.
    Li LH; Neil GL; Moxley TE; Olin EJ
    Cancer Chemother Rep; 1974; 58(3):345-52. PubMed ID: 4858297
    [No Abstract]   [Full Text] [Related]  

  • 4. Antileukemic properties of dichloro(1,2-diaminocyclohexane)platinum(II).
    Gale GR; Walker EM; Atkins LM; Smith AB; Meischen SJ
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):529-38. PubMed ID: 4824827
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
    Fujimoto S; Ogawa M; Sakurai Y
    Cancer Res; 1982 Oct; 42(10):4079-85. PubMed ID: 6955008
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antitumor chemotherapy. Considerations on the potential role of immunity].
    Mihich E
    Pathol Biol; 1967 Feb; 15(3):209-14. PubMed ID: 4860732
    [No Abstract]   [Full Text] [Related]  

  • 7. The antineoplastic and biochemical effects of some 5-fluoropyrimidines.
    Sartorelli AC; Creasey WA
    Cancer Res; 1967 Nov; 27(11):2201-6. PubMed ID: 6073510
    [No Abstract]   [Full Text] [Related]  

  • 8. Some determinants of camptothecin responsiveness in leukemia L1210 cells.
    Kessel D
    Cancer Res; 1971 Dec; 31(12):1883-7. PubMed ID: 5120286
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitumor activity of cyclocytidine in a variety of tumors.
    Hoshi A; Kanzawa F; Kuretani K
    Gan; 1972 Jun; 63(3):353-60. PubMed ID: 5072834
    [No Abstract]   [Full Text] [Related]  

  • 10. An outline of cancer chemotherapy.
    Connors TA
    Rev Roum Inframicrobiol; 1971; 8(3):135-51. PubMed ID: 5152643
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanism of action of ftorafur, a new antineoplastic agent].
    Meĭren DV; Belousova AK
    Vopr Med Khim; 1972; 18(3):288-93. PubMed ID: 4679596
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antineoplastic activity in mice of 4,4'-(2-methyl-1,4-piperazinodiyl)bis-(4-oxo)-propenyl-1-carboxylic-1 acid diethyl ester].
    Graczyk J; Pakulska W; Groszkowski S; Najman L
    Acta Pol Pharm; 1980; 37(2):249-54. PubMed ID: 7468274
    [No Abstract]   [Full Text] [Related]  

  • 13. Dextran derivatives in single and combination chemotherapy against transplantable mouse ascites and solid tumors.
    Suzuki M; Mikami T; Kadowaki M; Matsumoto T; Suzuki S
    Cancer Res; 1977 Sep; 37(9):3448-54. PubMed ID: 69495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ribonucleotide reductase, DNA synthesis, and L1210 leukemia by guanazole.
    Brockman RW; Shaddix S; Laster WR; Schabel FM
    Cancer Res; 1970 Sep; 30(9):2358-68. PubMed ID: 5475481
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of macromolecular biosynthesis in cultured L1210 mouse leukemia cells by thalicarpine (NSC 68075).
    Allen LM; Creaven PJ
    Cancer Res; 1973 Dec; 33(12):3112-6. PubMed ID: 4796799
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibitory effect of poriatin on murine leukemia 1210 cells].
    Xu J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Feb; 10(1):45-9. PubMed ID: 2968177
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy of 6-thioguanine with various antitumor agents against murine leukemia L-1210.
    Fujimoto S; Inagaki J; Horikoshi N; Hoshino A
    Gan; 1977 Oct; 68(5):543-52. PubMed ID: 201534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative biochemical studies of adriamycin and daunomycin in leukemic cells.
    Wang JJ; Chervinsky DS; Rosen JM
    Cancer Res; 1972 Mar; 32(3):511-5. PubMed ID: 5061305
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of diazan on DNA, RNA, and protein synthesis in mouse L1210 leukemia cells sensitive and resistant to the drug].
    Anikin IV; Kukushkina GV; Sokolova IS; Gorbacheva LB
    Izv Akad Nauk SSSR Biol; 1981; (2):291-5. PubMed ID: 7240552
    [No Abstract]   [Full Text] [Related]  

  • 20. A modified screening system to select new cytostatic drugs.
    Kraemer HP; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):301-28. PubMed ID: 6383326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.